NCT04087200 Protective Effect of Early High Dose stATins On Cardiovascular and Renal Events in Acute Coronary Syndrome
| NCT ID | NCT04087200 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Centro Cardiopatici Toscani |
| Condition | Acute Coronary Syndrome |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,500 participants |
| Start Date | 2016-12-01 |
| Primary Completion | 2025-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,500 participants in total. It began in 2016-12-01 with a primary completion date of 2025-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Registration of all ACS patients (STEMI and NSTEMI) admitted to the cardiology ward and scheduled for early invasive strategy. The aim is to evaluate the protective effects of early (on admission) high-dose high-potency statin therapy on early and mid-term cardiac and renal events in this subset of patients.
Eligibility Criteria
Inclusion Criteria: * Acute coronary syndrome (ST elevation and non ST elevation) * Early invasive strategy Exclusion Criteria: * contraindication to statin therapy * refusal of consent
Contact & Investigator
Frequently Asked Questions
Who can join the NCT04087200 clinical trial?
This trial is open to participants of all sexes, studying Acute Coronary Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04087200 currently recruiting?
Yes, NCT04087200 is actively recruiting participants. Contact the research team at anna.toso@libero.it for enrollment information.
Where is the NCT04087200 trial being conducted?
This trial is being conducted at Prato, Italy.
Who is sponsoring the NCT04087200 clinical trial?
NCT04087200 is sponsored by Centro Cardiopatici Toscani. The trial plans to enroll 2,500 participants.